As of 2025-11-07, the Relative Valuation of Pacira Biosciences Inc (PCRX) is (87.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 21.10 USD, the upside of Pacira Biosciences Inc based on Relative Valuation is -514.8%.
The range of the Relative Valuation is (91.23) - (100.48) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.2x - 42.2x | 34.8x |
| Forward P/E multiples | 20.3x - 35.4x | 26.8x |
| Fair Price | (91.23) - (100.48) | (87.52) |
| Upside | -532.4% - -576.2% | -514.8% |
| Date | P/E |
| 2025-11-06 | -7.44 |
| 2025-11-05 | -7.70 |
| 2025-11-04 | -7.91 |
| 2025-11-03 | -7.82 |
| 2025-10-31 | -7.54 |
| 2025-10-30 | -7.50 |
| 2025-10-29 | -7.41 |
| 2025-10-28 | -7.53 |
| 2025-10-27 | -7.52 |
| 2025-10-24 | -7.66 |
| 2025-10-23 | -7.64 |
| 2025-10-22 | -7.58 |
| 2025-10-21 | -7.76 |
| 2025-10-20 | -8.11 |
| 2025-10-17 | -8.06 |
| 2025-10-16 | -8.03 |
| 2025-10-15 | -8.27 |
| 2025-10-14 | -8.01 |
| 2025-10-13 | -7.85 |
| 2025-10-10 | -7.88 |
| 2025-10-09 | -8.13 |
| 2025-10-08 | -8.25 |
| 2025-10-07 | -8.33 |
| 2025-10-06 | -8.41 |
| 2025-10-03 | -8.76 |
| 2025-10-02 | -8.66 |
| 2025-10-01 | -8.91 |
| 2025-09-30 | -9.08 |
| 2025-09-29 | -8.93 |
| 2025-09-26 | -8.90 |
| 2025-09-25 | -9.04 |
| 2025-09-24 | -9.18 |
| 2025-09-23 | -9.24 |
| 2025-09-22 | -9.33 |
| 2025-09-19 | -9.40 |
| 2025-09-18 | -9.39 |
| 2025-09-17 | -9.19 |
| 2025-09-16 | -9.34 |
| 2025-09-15 | -9.47 |
| 2025-09-12 | -9.56 |
| 2025-09-11 | -9.53 |
| 2025-09-10 | -9.38 |
| 2025-09-09 | -9.27 |
| 2025-09-08 | -9.43 |
| 2025-09-05 | -9.32 |
| 2025-09-04 | -9.42 |
| 2025-09-03 | -9.58 |
| 2025-09-02 | -9.60 |
| 2025-08-29 | -9.40 |
| 2025-08-28 | -9.46 |